Although Japan still lags behind the United States, and much of Europe, in the development of its biotechnology sector, the country is making considerable effort to develop biotechnology as a major industry. As a result, the Japanese biotechnology industry has been making good progress in recent years. Much of the impetus has come from the Japanese government which has been providing considerable support to foster this industry. The industry's rapid development is a visible result of the close cooperation between the Japanese public and private sectors and academia. In 2007, the total market size of the Japanese biotechnology industry was USD19.5 billion, a 10.8 percent increase over 2006. Currently medical biotechnology is the leading sub-sector. Medical biotechnology products account for over 30 percent of the Japanese biotechnology market. Within medical biotechnology, therapeutic antibodies have the highest growth potential. Japanese pharmaceutical companies are eagerly seeking new drug candidates and pipelines, identified or developed by overseas biotech companies, which they can tap into in order to develop new drugs.Developing any new business venture is difficult. Taking a project from the initial idea through the operational stage is a complex and time consuming effort. Before the potential members invest in a proposed business project, they must determine if it can be economically viable and then decide if investment advantages outweigh the risks involved. The feasibility study allows groups to preview potential project outcomes and to decide if they should continue. It is an integral part in developing a new project. The purpose of the feasibility study is to explore the project in enough detail for the interested parties and stake holders to make a commitment to proceed with the development of the project.Feasibility studies are useful and valid for many kinds of projects. An evaluation of a new business venture both for new groups and established businesses, is the most common, but not the only usage. Studies can help groups to expand existing services, build or remodel facilities, change methods of operation, add new products, or even merge with another business. A feasibility study assists decision makers whenever they need to consider alternative development opportunities.VENN Research's feasibility is intends to help the foreign exporters and companies to identify the market opportunities in a particular geography and a vertical. It covers the following aspects:' Current market scenario and trends' Export and Import trends' Market competition and players' Policies, Laws and Regulatory Initiatives in the industry' Opportunities and Threats' Distribution Channel Strategy' Market Entry Strategy' Industry Contacts and Relevant Events
Market Feasibility Report ' Japan Biotechnology Market
1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Market Feasibility Report ' Japan Biotechnology Market
Published on July 2009
Report Summary
Although Japan still lags behind the United States, and much of Europe, in the development of its biotechnology sector, the country is
making considerable effort to develop biotechnology as a major industry. As a result, the Japanese biotechnology industry has been
making good progress in recent years. Much of the impetus has come from the Japanese government which has been providing
considerable support to foster this industry.
The industry's rapid development is a visible result of the close cooperation between the Japanese public and private sectors and
academia. In 2007, the total market size of the Japanese biotechnology industry was USD19.5 billion, a 10.8 percent increase over
2006. Currently medical biotechnology is the leading sub-sector.
Medical biotechnology products account for over 30 percent of the Japanese biotechnology market. Within medical biotechnology,
therapeutic antibodies have the highest growth potential. Japanese pharmaceutical companies are eagerly seeking new drug
candidates and pipelines, identified or developed by overseas biotech companies, which they can tap into in order to develop new
drugs.
Developing any new business venture is difficult. Taking a project from the initial idea through the operational stage is a complex and
time consuming effort. Before the potential members invest in a proposed business project, they must determine if it can be
economically viable and then decide if investment advantages outweigh the risks involved. The feasibility study allows groups to
preview potential project outcomes and to decide if they should continue. It is an integral part in developing a new project. The
purpose of the feasibility study is to explore the project in enough detail for the interested parties and stake holders to make a
commitment to proceed with the development of the project.
Feasibility studies are useful and valid for many kinds of projects. An evaluation of a new business venture both for new groups and
established businesses, is the most common, but not the only usage. Studies can help groups to expand existing services, build or
remodel facilities, change methods of operation, add new products, or even merge with another business. A feasibility study assists
decision makers whenever they need to consider alternative development opportunities.
VENN Research's feasibility is intends to help the foreign exporters and companies to identify the market opportunities in a particular
geography and a vertical. It covers the following aspects:
' Current market scenario and trends
' Export and Import trends
' Market competition and players
' Policies, Laws and Regulatory Initiatives in the industry
' Opportunities and Threats
' Distribution Channel Strategy
' Market Entry Strategy
' Industry Contacts and Relevant Events
Market Feasibility Report ' Japan Biotechnology Market Page 1/5
2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Table of Content
1 About the Report
2 Executive Summary
3 Japan Biotechnology Market, 2012
4 Japan Biotechnology Market, By Bio-Products
4.1 Drugs (Bio-pharmaceuticals)
4.2 Bio-services
4.3 Functional Foods
5 Japan Biotechnology Market, By Sectors
6 Japans High-Level Technological Capability
7 Growth in Bio-Ventures in Japan
8 Regional Opportunities
9 Market Players, By Sector
9.1 Biopharmaceutical Products
9.2 Diagnostics and Other Biomedical Products
9.3 Japanese Emerging Biotech Companies
10 PORTER'S Five Forces Analysis
10.1 Buyers Power
10.2 Supplier Power
10.3 New Entrants
10.4 Substitutes
10.5 Rivalry
11 Company Profiles
11.1 Takara Holdings Inc.
11.2 Daiichi Sankyo, Ltd.
11.3 Mitsubishi Tanabe Pharma Corporation
11.4 Astellas Pharma
12 Japan Biotechnology Market Outlook, 2012
13 Best Product Prospects
14 Market Entry
15 Market Barriers & Challenges
16 Industry Exhibitions and Trade Meets
Market Feasibility Report ' Japan Biotechnology Market Page 2/5
3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
17 Industry Contacts
List of Figures:
Figure 1: Market Size of Bio-pharmaceuticals
Figure 2: Market Size of Bio-services
Figure 3: Market Size of Functional Foods
Figure 4: Japan Biotechnology Market, By Sectors, (%)
Figure 5L Patent applications on life science by sector/applicants' nationality between 1991- 2000
Figure 6: Number of venture startups and implementation of related measures
Figure 7: Japan Biotechnology Market Outlook, (USD Billions), 2007-2012
Figure 8: Japan Biotechnology Market, By Segmentation, (Trillion Yen), 2010
Market Feasibility Report ' Japan Biotechnology Market Page 3/5
4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Market Feasibility Report ' Japan Biotechnology Market
Product Formats
Please select the product formats and the quantity you require.
License not available
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Market Feasibility Report ' Japan Biotechnology Market Page 4/5
5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Market Feasibility Report ' Japan Biotechnology Market Page 5/5